TF and cancer: In addition, although pharmacologic inhibition of a TF or cofactor that acts widely on genes throughout the genome can exert highly selective effects on cancer control due to its oncogenic addiction in cancer cells, only very few have been successfully advanced by coordinated efforts in drug discovery, in part due to lacking knowledge of the detailed structural and functional nature in cells.